Glenmark Pharmaceuticals and Glenmark Generics Inc., USA (Glenmark) has confirmed that Cephalon Inc. has filed a patent infringement suit on December 26, 2013 in the US District Court for the District of Delaware seeking to prevent Glenmark from commercializing its Abbreviated New Drug Application (ANDA) Bendamustine Hydrochloride product, their generic version of Treanda, prior to expiration of the Orange Book patents. This lawsuit was filed under the provisions of the Hatch-Waxman Act.
Epic Research
Tuesday, December 31, 2013
EPIC UPDATE : GLENMARK PHARMACEUTICALS
Labels:
Best Stock Tips,
Best Tips For Intraday,
Bullion Tips,
Commodity Tips,
equity tips,
Equity Tips Free Trial,
Forex Tips,
Forex Tips MCX Tips,
Free Trial,
MCX Tips,
NCDEX Tips,
NCDEX Tips.,
Penny Stock Tips,
share market,
share tips,
share tips india,
stock tips,
stock tips india,
Stock Trading Tips.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment